The Wall Street Journal
Brent Kendall and
Jared S. Hopkins
Pharmaceutical giant is latest to be indicted in long-running investigation into generic-drug industry
WASHINGTON — The U.S. business of Teva Pharmaceutical Industries Ltd.
has been indicted on charges the drugmaker fixed prices on generic drugs, according to a person familiar with the matter.
The Justice Department is expected to announce the charges imminently, the person said.